Dr. Srikanth Naramala, MD

Dr. Naramala practices at Complete Care Community Health Center in Los Angeles, California.

Dr. Naramala's NPI, 1437412129, was assigned on June 19, 2012. Dr. Naramala graduated from Andhra Medical College NTR in 2008. Dr. Naramala holds California license A1455595.

Dr. Naramala's primary practice is Complete Care Community Health Center, at 2928 E Cesar Chavez Ave, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 266-6700.

Dr. Naramala's primary practice is Complete Care Community Health Center in Los Angeles, California. Dr. Naramala is also affiliated with Kaweah Health Medical Center. The medical group on file is Complete Care Community Health Center. Dmand AI also links Dr. Naramala to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account. Dr. Naramala's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Naramala practices, 8 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Naramala's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Naramala is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Naramala's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Naramala treats.

CMS data shows 38,121 Medicare services from Dr. Naramala across 16 procedure codes in 2024, for 566 Medicare patients. Medicare paid $395,961 for them. Every service was in an office.

CMS counts 566 Medicare patients who saw Dr. Naramala in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Naramala's median patient age at 69, with 82% women.

In 2024, Dr. Naramala wrote 7,829 Medicare Part D claims for 1,321 patients. 56% of them were for generic drugs. CMS names the drug for 7,241 of them, across 74 drugs with 11 or more claims each, at $14,529,472 in total drug cost. In 2023, CMS named 4,918 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 23 out of 100 for Dr. Naramala for performance year 2024, reported individually.

Dmand AI links 75 papers to Dr. Naramala, published from 2019 to 2022. 2020 was the busiest year, with 33. The most frequent topics are COVID-19, SARS-CoV-2 and Betacoronavirus. Dr. Naramala has published most often in Cureus. Dr. Naramala's most frequent co-authors are Sreedhar Reddy Adapa, MD, Venu Madhav Konala, MD and Subhasish Bose, MD.

CMS Open Payments shows 340 general payments to Dr. Naramala from 24 drug and device companies from 2017 to 2025. Honoraria make up the largest share, 59% of the total. Aurinia Pharma U.S., Inc. paid the most, $15,130.

Dr. Naramala graduated from Andhra Medical College NTR in 2008. Dr. Naramala is a member of ACP, ACR and AMA.

Dr. Naramala is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.